News about Research
- Jan (21)
- Feb (19)
- Mar (23)
- Apr (22)
- May (22)
- Jun (20)
- Jul (27)
- Aug (10)
- Sep (24)
- Oct (23)
- Nov (34)
- Dec (16)
- Jan (24)
- Feb (27)
- Mar (15)
- Apr (23)
- May (34)
- Jun (28)
- Jul (26)
- Aug (11)
- Sep (19)
- Oct (20)
- Nov (28)
- Dec (14)
- Jan (14)
- Feb (22)
- Mar (21)
- Apr (12)
- May (20)
- Jun (23)
- Jul (20)
- Aug (5)
- Sep (19)
- Oct (19)
- Nov (26)
- Dec (15)
- Jan (4)
- Feb (18)
- Mar (13)
- Apr (15)
- May (19)
- Jun (22)
- Jul (18)
- Aug (9)
- Sep (11)
- Oct (25)
- Nov (19)
- Dec (15)
- Jan (12)
- Feb (6)
- Mar (13)
- Apr (5)
- May (7)
- Jun (15)
- Jul (11)
- Aug (3)
- Sep (5)
- Oct (8)
- Nov (15)
- Dec (13)
Mechanism responsible for the loss of identity of hepatocytes in alcoholic hepatitis described
Pau Sancho-Bru and his team lead the study that links CXCR4 with the process of dedifferentiation of hepatocytes and tissue damage.
The Clinic-IDIBAPS receives an Edmond J. Safra Fellowship from the Michael J. Fox Foundation to train a neurologist specialised in movement disorders
The period for submitting applications for the fellowship, which will last two years, from 2024 to 2026, is now open. Francesc Valldeoriola, a neurol1
Deep brain stimulation improves symptoms in patients with treatment-resistant schizophrenia and bipolar disorder
Led by researchers from IDIBAPS-Hospital Clínic Barcelona, the study shows that the technique can be a safe and effective alternative for complex cas1
Josep M. Llovet appointed editor-in-chief of the Journal of Hepatology Reports
The candidature of the Clínic-IDIBAPS researcher was approved with 90% of the votes at the general assembly of the European Association for the Study1
IDIBAPS creates three multidisciplinary research programs to encourage collaboration among its groups
They are the Translational cancer research program, the Synaptic autoimmunity in neurology, psychiatry and cognitive neuroscience program and the Lym1
The ”la Caixa” Foundation and the Hospital Clínic Barcelona renew their cancer research alliance
The ”la Caixa” Foundation will allocate 4.6 million euros to promoting research at the Hospital Clínic Barcelona, in order to develop new, personaliz1
The CAR T-cell therapy from the Hospital Clínic-IDIBAPS for multiple myeloma is effective in patients with refractory disease
A multicentre study led by the Hospital Clínic Barcelona-IDIBAPS demonstrates the efficacy of the CAR T-cell therapy ARI0002h in treating patients wi1
Researchers at IDIBAPS Hospital-Clínic Barcelona receive two grants from the Mutua Madrileña Foundation
One of the projects is coordinated by Glòria Garrabou, the head of the group Hereditary metabolic diseases and muscular diseases, and the other by Os1
First genetic marker for Multiple Sclerosis severity identified
This finding, published today in the journal Nature, opens the door to the development of new treatments to prevent long-term disability.